EP2389097A1 - Système et procédé d'analyse d'un liquide corporel - Google Patents

Système et procédé d'analyse d'un liquide corporel

Info

Publication number
EP2389097A1
EP2389097A1 EP10700410A EP10700410A EP2389097A1 EP 2389097 A1 EP2389097 A1 EP 2389097A1 EP 10700410 A EP10700410 A EP 10700410A EP 10700410 A EP10700410 A EP 10700410A EP 2389097 A1 EP2389097 A1 EP 2389097A1
Authority
EP
European Patent Office
Prior art keywords
test element
body fluid
reservoir
collecting
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10700410A
Other languages
German (de)
English (en)
Other versions
EP2389097B1 (fr
Inventor
Volker Zimmer
Wolfgang Petrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Priority to EP10700410.3A priority Critical patent/EP2389097B1/fr
Publication of EP2389097A1 publication Critical patent/EP2389097A1/fr
Application granted granted Critical
Publication of EP2389097B1 publication Critical patent/EP2389097B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00009—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with a sample supporting tape, e.g. with absorbent zones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • A61B5/1405—Devices for taking blood samples
    • A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150358—Strips for collecting blood, e.g. absorbent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150419—Pointed piercing elements, e.g. needles, lancets for piercing the skin comprising means for capillary action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A61B5/150511—Details of construction of shaft
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146—Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/8483—Investigating reagent band
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1065—Multiple transfer devices
    • G01N35/1067—Multiple transfer devices for transfer to or from containers having different spacing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters

Definitions

  • the invention relates to a system or a device for analyzing a body fluid with a collecting element receiving the fluid in a reservoir, a test element designed to detect an analyte in the fluid, a transfer device for establishing a fluidic connection between the collecting element and the test element, and a detection unit detecting an analyte-specific measurement signal on the test element during a measurement interval.
  • the invention further relates to a corresponding analysis method.
  • the object of the invention is to further develop the products and methods known from the prior art and to provide a configuration that is also optimized with regard to the provision / disposal of the expendable parts and reproducible measurement results.
  • the transfer device permanently bring the test element into fluid contact with the body fluid in the reservoir during the measurement interval, so that a liquid column is maintained on a detection surface of the test element, and that the transfer device is adapted to mount the test element and the collection element after the test element Measuring interval physically separate from each other. Due to a sufficient volume of liquid on the detection surface, reaction processes and in particular diffusion processes proceed uniformly, without layer thickness effects still playing an essential role with regard to tolerances.
  • the liquid column stands on or above the surface of the test element and thus has a liquid level in a space bounded by the collecting element.
  • the use of separate elements for liquid recovery and analytical detection requires an active assembly, so that the reaction start can be precisely defined.
  • simplified handling is also ensured in advance with regard to sterilization and storage, while the separation after the measurement means that the disposal can take place in a form which corresponds to the previous provision, so that also the storage is facilitated.
  • this configuration avoids contamination of the collecting element with the test chemistry and thus a risk of body contact or a reduction in hydrophilic properties.
  • the liquid volume of the reservoir is determined such that the liquid column does not fall below a minimum height above the detection surface for the duration of the measurement interval.
  • the minimum height of the liquid column is more than 10 ⁇ m, preferably more than 50 ⁇ m.
  • the test element is larger than the actually detected detection area.
  • the test field should be designed to distribute the body fluid during the measurement interval in a Spreit Scheme area, while ensuring that the size of the Spreitrios and the volume of the reservoir are coordinated so that during the measurement interval on the detection surface is maintained a liquid column.
  • the reservoir has a depth between 50 and 150 microns, a width between 50 and 150 microns and a length of more than 1 mm, preferably about 2 mm.
  • the detection surface has a size in the range of 0.1 mm 2 to 1 mm 2 .
  • the analyte-specific measurement signal is detected in a time range of 0 to 15 s after the fluidic connection between the collection and test element has been established.
  • the end of the measuring interval can be determined by the fact that the change of the measuring signal in the time unit reaches a predetermined value.
  • a particularly preferred embodiment provides that the collecting element and test element are spaced apart in a starting state as separate components, so are physically separated from each other, and that the fluidic connection by distance reduction with active movement of the collecting element and / or the test element can be produced.
  • the initial separation of the components also offers multiple advantages in terms of simplified manufacturing and application possibilities.
  • it is advantageous if the fluid intake is effected by a lancing process, and if the fluidic connection of the collecting element to the test element is produced only after the lancing process.
  • the reservoir is formed by a capillary structure, in particular a linear capillary channel or capillary gap. Furthermore, it is advantageous if the detection surface is designed as a dry chemical layer, in particular on the enzyme basis for a photometric detection, and if the collecting element is provided at least in the region of the reservoir with a hydrophilic coating.
  • Benefits for use also result from the fact that the collecting element and the test element after the measurement interval, for example, for a separate disposal as disposable parts are again separated from each other. This is preferably done by means of the transfer device, which brings the initially separated components in a defined contact state for the measurement, which is no longer needed after completion of the measurement.
  • a fluidic connection is established between a collecting element containing the body fluid in a reservoir and a test element designed to detect an analyte in the body fluid, during a measuring interval an analyte-specific measuring signal is indicated detected the test element, the test element is permanently brought during the measurement interval in contact with the body fluid located in the reservoir, so that a liquid column is maintained on a detection surface of the test element, the test element and the collecting element are separated from each other after the measuring interval.
  • FIG. 1 shows a diagnostic analysis system in a simplified perspective view
  • the analysis system 10 illustrated in FIG. 1 comprises in the form of a handheld device for carrying out blood glucose tests a carrier tape 12 having a multiplicity of collection elements 14 for body fluid (blood or tissue fluid) and a separate carrier band 16 for storing a corresponding number of test elements 18. a sample transfer device 20 and a detection unit 22. By tape transport, a collecting element 14 and a test element 18 can each be provided on a band guide 24 for a single use.
  • the sample transfer device 20 is set up such that the active test element 18 is always exposed to body fluid during a measurement interval.
  • the carrier tapes 12, 16 with the collecting elements 14 or test elements 18 located thereon can be provided in the form of respective tape cassettes, so that a separate storage and disposal is possible.
  • Other forms of separate storage also For example, in stack form are conceivable. Due to the separate arrangement, it is possible to sterilize the collecting elements 14 independently of the test elements 18, for example by high-energy irradiation. In addition, a separate fabric-tight packaging can also guarantee longer storage times without quality disadvantages.
  • the collecting elements 14 may be configured to receive the body fluid directly on site.
  • the collecting elements 14 can each have a tip 26 for a skin puncture and a reservoir for receiving body fluid in the form of a half-open capillary tube 28 over its length.
  • test elements 18 are provided as test fields with an enzyme-based dry chemistry layer 30 for optical glucose detection.
  • the detection by means of a color change can take place through transparent structures by means of a photometric detection unit 22, as described in more detail, for example, in EP-A 1760469.
  • Fig. 2 illustrates three different process stages in the use of the pairwise associated collection and test elements.
  • the collecting element 14 is physically separated at a distance from the test element 18.
  • the capillary 28 is filled with body fluid 32.
  • the surface of the collecting element 14 may be provided with a hydrophilic coating 34 at least in the region of the capillary 28.
  • Typical dimensions of capillary 28 for special applications are about 120 ⁇ m in width b, about 80 ⁇ m in depth t and about 2 mm in length.
  • the measured value is acquired.
  • a fluidic connection between the collecting element 14 and the test element 18 for a sample transfer is produced by means of an actuator of the transfer device 20 symbolized by a double arrow 36 in FIG. 1 while reducing the distance.
  • the capillary 28 is placed on the dry chemical layer 30 on the opening side, wherein the area acted on by the body fluid 32 forms a detection surface 38 with an area of about 0.2 mm 2 for the photometric measurement acquisition.
  • the measurement is carried out in the contact state of the collecting element 14 back through the transparent carrier tape 16 therethrough.
  • the detection unit 22 has a light source 40 and a light receiver 42 in a reflectometric arrangement.
  • a liquid column 44 delimited by the capillary 28 is retained on the detection surface 38.
  • the liquid column 44 is thus located in a limited by the collecting element 14 space above the wetted surface of the test element 18.
  • the dimensions of the capillary 28 are chosen so that a minimum height of the liquid column 44 of about 50 microns at least over the range of optically scanned detection area 38 is not exceeded. In this case, it is also taken into account by means of a sufficient capillary volume as a reservoir that the dry chemical layer 30 is provided with a spreading surface which distributes the body fluid 32 in a spreading region 46 in a planar manner.
  • the transfer device 20 is also designed to actively separate the collecting element 14 and the test element 18 again after the measurement by means of an actuator 36. In this way, a separate disposal is possible according to the initial situation. In the embodiment shown, this is done in the form of separate bands 12, 16, which greatly simplify re-storage. The Users can thus use consumer units in the device 10, which enable a variety of tests without complex handling.
  • FIG. 3 shows the time profile of a signal detected by means of the detection unit 22.
  • the measuring interval comprises at least one such time window in which the observation of a signal course based on a reaction of the analyte (glucose) is possible. This can be done with the goal to analyze the reaction kinetics, or to directly determine a concentration value.
  • analyte glucose
  • the detection is based on a change in the color of the detection surface 38 caused by the analyte-specific reaction, which is detected as a gray-scale course ⁇ l in remission. While initially a blank value or zero value is still observed in the separated state, an analyte-specific signal drop occurs with the contact according to FIG. 2b, which finally approaches a final value characteristic of the glucose concentration.
  • the duration of the measurement interval in which the analyte-specific signal is detected can be defined by a predetermined limit value of the signal change per unit time. For example, the measurement could be aborted if the signal changes less than 3% per second. The measurement period is then usually below 8s.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

La présente invention concerne un système qui est destiné à l'analyse d'un liquide organique (32) et qui comporte un élément collecteur (14) recevant ce dernier dans un réservoir (28), un élément de test (18) permettant de mettre en évidence un analysat qui s'est formé dans le liquide organique (32), un dispositif de transfert (20) permettant d'établir une liaison fluidique entre l'élément collecteur (14) et l'élément de test (18), et une unité de détection (22) qui, pendant un intervalle de mesure, détecte au niveau de l'élément de test (18) un signal de mesure spécifique de l'analysat. L'invention tient au fait, d'une part que, pendant l'intervalle de mesure, le dispositif de transfert (20) maintient l'élément de test (18) en contact continu avec le liquide organique (32) se trouvant dans le réservoir, et d'autre part, que le dispositif de transfert (20) est configuré de façon à séparer de l'élément de test (18) l'élément collecteur (14) après l'intervalle de mesure.
EP10700410.3A 2009-01-16 2010-01-14 Système et procédé destinés à l'analyse d'un liquide corporel Not-in-force EP2389097B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10700410.3A EP2389097B1 (fr) 2009-01-16 2010-01-14 Système et procédé destinés à l'analyse d'un liquide corporel

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20090150807 EP2208459A1 (fr) 2009-01-16 2009-01-16 Système et procédé destinés à l'analyse d'un liquide corporel
EP10700410.3A EP2389097B1 (fr) 2009-01-16 2010-01-14 Système et procédé destinés à l'analyse d'un liquide corporel
PCT/EP2010/050395 WO2010081848A1 (fr) 2009-01-16 2010-01-14 Système et procédé d'analyse d'un liquide corporel

Publications (2)

Publication Number Publication Date
EP2389097A1 true EP2389097A1 (fr) 2011-11-30
EP2389097B1 EP2389097B1 (fr) 2014-11-26

Family

ID=40673318

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20090150807 Withdrawn EP2208459A1 (fr) 2009-01-16 2009-01-16 Système et procédé destinés à l'analyse d'un liquide corporel
EP10700410.3A Not-in-force EP2389097B1 (fr) 2009-01-16 2010-01-14 Système et procédé destinés à l'analyse d'un liquide corporel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20090150807 Withdrawn EP2208459A1 (fr) 2009-01-16 2009-01-16 Système et procédé destinés à l'analyse d'un liquide corporel

Country Status (13)

Country Link
US (1) US9128066B2 (fr)
EP (2) EP2208459A1 (fr)
JP (1) JP5612607B2 (fr)
KR (1) KR101717794B1 (fr)
CN (1) CN102281814B (fr)
AU (1) AU2010205619B2 (fr)
BR (1) BRPI1006854B8 (fr)
CA (1) CA2749052C (fr)
HK (1) HK1164670A1 (fr)
MX (1) MX2011007453A (fr)
RU (1) RU2545790C2 (fr)
SG (2) SG196822A1 (fr)
WO (1) WO2010081848A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2663732C1 (ru) * 2017-05-04 2018-08-09 Игорь Михайлович Рулев Способ автоматического отбора и упаковки микробиологических объектов
EP3661419B1 (fr) * 2017-08-02 2021-06-30 Roche Diabetes Care GmbH Agencement et procédé de test de glucose
EP3477287A1 (fr) * 2017-10-26 2019-05-01 Roche Diabetes Care GmbH Système et procédé de mesure d'analyte
WO2021134014A1 (fr) * 2019-12-27 2021-07-01 Sean Kelly Analyse d'un échantillon biologique à l'aide d'un transfert fluidique de bande à bande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801057A (en) * 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
ES2269717T3 (es) * 2001-06-08 2007-04-01 Roche Diagnostics Gmbh Dispositivo de extraccion de muestras de fluido corporal y cartucho con el medio de analisis que se utilizara con dicho dispositivo.
US7303726B2 (en) * 2002-05-09 2007-12-04 Lifescan, Inc. Minimal procedure analyte test system
DE10332488A1 (de) * 2003-07-16 2005-02-24 Roche Diagnostics Gmbh Analysegerät und Analyseverfahren für Körperflüssigkeiten
US20050137471A1 (en) * 2003-12-18 2005-06-23 Hans-Peter Haar Continuous glucose monitoring device
CN101690665B (zh) * 2004-03-06 2011-12-14 霍夫曼-拉罗奇有限公司 体液采样设备
EP1627684A1 (fr) * 2004-08-20 2006-02-22 F. Hoffmann-La Roche Ag Système microfluidique et son procédé de fabrication
EP1759633A1 (fr) * 2005-09-01 2007-03-07 F.Hoffmann-La Roche Ag Dispositif pour l'extraction de fluide corporel et méthode pour la fabrication de celui-ci
EP1760469A1 (fr) 2005-09-01 2007-03-07 F.Hoffmann-La Roche Ag Dispositif de test pour fluides corporels avec un élément optique tournant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010081848A1 *

Also Published As

Publication number Publication date
BRPI1006854B1 (pt) 2021-02-09
SG196822A1 (en) 2014-02-13
CN102281814A (zh) 2011-12-14
BRPI1006854A2 (pt) 2020-09-15
RU2545790C2 (ru) 2015-04-10
KR20110110191A (ko) 2011-10-06
EP2389097B1 (fr) 2014-11-26
KR101717794B1 (ko) 2017-03-17
AU2010205619A1 (en) 2011-08-04
SG173024A1 (en) 2011-08-29
RU2011134297A (ru) 2013-02-27
CA2749052C (fr) 2017-07-11
JP2012515028A (ja) 2012-07-05
BRPI1006854B8 (pt) 2021-06-22
US9128066B2 (en) 2015-09-08
EP2208459A1 (fr) 2010-07-21
AU2010205619B2 (en) 2014-11-20
CA2749052A1 (fr) 2010-07-22
JP5612607B2 (ja) 2014-10-22
HK1164670A1 (en) 2012-09-28
WO2010081848A1 (fr) 2010-07-22
CN102281814B (zh) 2014-10-29
US20120006105A1 (en) 2012-01-12
MX2011007453A (es) 2011-07-21

Similar Documents

Publication Publication Date Title
DE60124181T2 (de) Mikrohohlnadelpflaster
DE60303987T2 (de) Flüssigkeitssensor mit integrierter Lanzette
EP1880671B1 (fr) Roue de lancettes
DE10105549A1 (de) System zur Überwachung der Konzentration von Analyten in Körperflüssigkeiten
DE2907787C2 (fr)
EP2800515B1 (fr) Tube de prélèvement de sang muni d'un dispositif de détection intégré
DE69931469T2 (de) Vorrichtung zum füllen mittels kapillar-aktion
DE10010587A1 (de) System zur Bestimmung von Analytkonzentrationen in Körperflüssigkeiten
EP2234536A1 (fr) Système de détection d'un analyte dans un liquide corporel
EP2016899A1 (fr) Dispositif et procédé destinés au gain de liquides corporels
DE102004033317A1 (de) Analytisches Testelement
WO2008068215A2 (fr) Dispositif et procédé pour analyser des liquides corporels
EP2389097B1 (fr) Système et procédé destinés à l'analyse d'un liquide corporel
EP2173240B1 (fr) Article de diagnostic à usage unique
EP2502054B1 (fr) Procédé et dispositif destinés à l'examen d'un liquide corporel
EP2464290B1 (fr) Element test pour l'analyse d'un liquide corporel
DE102013000922B4 (de) Vorrichtung zur schnellen Aufnahme und Abgabe von Proben, System mit einem Probenehmer und dessen Verwendung
EP2384699B1 (fr) Cartouche de lancettes et son procédé de fabrication
EP3757571B1 (fr) Unité d'essai d'écoulement, ensemble et utilisation d'une unité d'essai d'écoulement pour mettre en uvre une réaction de détection
DE102005003961A1 (de) Vorrichtung und Verfahren zur Untersuchung von Probenflüssigkeit
DE10164834B4 (de) Aufnahme für Proben und Komplettfolie zum Aufnehmen von Proben
EP3524350A1 (fr) Dispositif et procédé d'analyse de liquide
EP2284534B1 (fr) Elément de test destiné à l'analyse d'un liquide corporel
DE2557060C3 (de) Verfahren und Vorrichtung zur Bestimmung von in Lösung befindlichen Ionen
EP2710109B1 (fr) Procédé et utilization d'un dispositif pour la détermination automatique de la position d'un microsystème pour la manipulation d'un micro-objet sphérique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ZIMMER, VOLKER

Inventor name: PETRICH, WOLFGANG

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120807

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 502010008336

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61B0005000000

Ipc: A61B0005145500

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/487 20060101ALI20140505BHEP

Ipc: A61B 5/151 20060101ALI20140505BHEP

Ipc: A61B 5/1455 20060101AFI20140505BHEP

Ipc: G01N 33/00 20060101ALI20140505BHEP

Ipc: A61B 5/145 20060101ALI20140505BHEP

INTG Intention to grant announced

Effective date: 20140519

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140917

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 697713

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502010008336

Country of ref document: DE

Effective date: 20150108

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20141126

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150226

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150326

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150326

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150227

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010008336

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150114

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

26N No opposition filed

Effective date: 20150827

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150114

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 697713

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150114

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502010008336

Country of ref document: DE

Representative=s name: PFIZ/GAUSS PATENTANWAELTE PARTMBB, DE

Ref country code: DE

Ref legal event code: R082

Ref document number: 502010008336

Country of ref document: DE

Representative=s name: WOLF, PFIZ & GAUSS PATENTANWAELTE PARTNERSCHAF, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 502010008336

Country of ref document: DE

Owner name: ROCHE DIABETES CARE GMBH, DE

Free format text: FORMER OWNER: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150114

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20100114

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141126

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20201231

Year of fee payment: 12

Ref country code: FR

Payment date: 20201223

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20210121

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20201218

Year of fee payment: 12

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502010008336

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220114

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220114

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220802

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220114